Healthcare Industry Insights

Thursday, 19 March 2020

Ophthalmic Ultrasound Devices Market - Global Forecasts to 2026 by Grand View Research, Inc.

19-Mar-2020: The global ophthalmic ultrasound devices market size is expected to reach USD 728.7 million by 2026, according to a new report by Grand View Research, Inc., growing at a CAGR of 6.1%. Increasing burden of ophthalmic disorders, such as cataract & retinal detachments, and high demand for effective imaging tools are factors driving growth. In addition, frequent new product launches are expected to contribute toward high growth during the forecast period.

Advanced technology with integrated scanning features is expected to replace the existing conventional devices. Rising number of private as well as non-profit ophthalmic clinics and ambulatory imaging centers in developing countries is expected to play an important role in driving the global ophthalmic ultrasound systems market.

Increasing incidence of diabetes, a major factor leading to ophthalmic disorders such as cataract & proliferative diabetic retinopathy, growing awareness about cataract surgeries, and introduction of technologically advanced devices are some of factors anticipated to drive the market over the forecast period.

Growing number of strategic initiatives, such as introduction of technologically advanced and integrated devices at competitive prices, establishing of exclusive agreement with hospitals & clinics, and mergers & acquisitions also aid growth. Moreover, establishment of ophthalmology society and evolving government and non-government programs supporting eye care are expected to boost the market.

In depth research report on Ophthalmic Ultrasound Devices Market

https://www.grandviewresearch.com/industry-analysis/ophthalmic-ultrasound-devices-market

Further key findings from the report suggest:

· The A-scan segment held largest share and is expected to grow at lucrative CAGR over the forecast period owing to its increasing demand as critical imaging equipment in cataract surgery

· Ocular ultrasounds that are portable with integrated scanning features are anticipated to witness fastest growth during the forecast period

· Hospital segment accounted for the largest share in 2018. Large patient pool and government support in the form of funding for advancement of eye care in different geographies are expected to contribute toward growth of this segment

· North America dominated in 2018. Growth of this region is fueled by local presence of major manufacturers and suppliers developing advance technology coupled with rising prevalence of ophthalmic disorders

· Asia Pacific is anticipated to witness fastest growth over the forecast period due to improving healthcare infrastructure and growing economies

· Major players in the ophthalmic ultrasound devices market are focusing on launch of advance technology with improved parameters, such as image resolutions & data storage, and building efficient software for improving user interface.

Grand View Research has segmented the ophthalmic ultrasound devices market on the basis of product, end use, mobility, and region:

Ophthalmic Ultrasound Devices Product Outlook (Volume, ‘000 Units; Revenue, USD Million, 2015 - 2026)

· A-Scan

· B-Scan

· Combined

· Pachymeter

· Ultrasound Biomicroscope

Ophthalmic Ultrasound Devices End-use Outlook (Revenue, USD Million, 2015 - 2026)

· Hospitals

· Ambulatory surgical Centre

· Ophthalmic clinic

· others

Ophthalmic Ultrasound Devices Mobility Outlook (Revenue, USD Million, 2015 - 2026)

· Standalone

· Portable/ Handheld

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/medical-devices

About Grand View Research

Grand View Research, Inc. is the U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Wednesday, 18 March 2020

Acromegaly Treatment Market size is Anticipated to Reach USD 2.10 Billion by 2025: Grand View Research, Inc.

19-Mar-2020: The global acromegaly treatment market size is expected to reach USD 2.10 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.5% over the forecast period. Increasing incidence of the acromegaly disease is expected to drive the growth. For instance, the disease prevalence increased fourfold in 2015 from its previous year 2014, according to a report by the Endocrine Society. Moreover, growing investment in clinical trials by various pharmaceutical companies to develop new molecules is another factor propelling the market growth.

Furthermore, strong pipeline of drugs is anticipated to create growth opportunities in the forthcoming years. For instance, Mycapssa by Chiasma Inc. received approval in Europe in 2016. In 2018, Antisense Therapeutics launched their new formulation ALT1103 in U.S. ISIS 766720 by Ionis Pharmaceuticals Inc., a growth hormone receptor antagonist is currently under phase II clinical trial and is expected to be finished by December 2019.

The strong pipeline of drugs for somatostatin analogs is expected to propel growth of the acromegaly treatment market in near future. For instance, in 2018 around 30 clinical trials were being conducted in North America and many are waiting for the U.S. Food and Drug Administration (FDA) approval.

In depth research report on Acromegaly Treatment Market

https://www.grandviewresearch.com/industry-analysis/acromegaly-treatment-market

Further key findings from the report suggest:

· Somatostatin analogs segment is expected to emerge as the largest product segment in terms of revenue share in the forthcoming years, owing to easy availability and cost-effective treatment procedure of the product

· Hospital and clinics end use segment accounted for the largest market share as all the surgical procedures are performed in these facilities. Easy availability of surgeons Is anticipated to further drive the segment

· North America held the dominant market share in 2018, due to favorable government insurance policies and increased investment in R&D by the pharmaceutical companies. For instance, In May 2018, U.S. Congress approved the Right to Try bill, wherein patients can try unproven medical therapeutics in case of serious illness including orphan diseases like acromegaly

· Asia Pacific acromegaly treatment market is anticipated to witness lucrative growth in near future due to rising healthcare expenditure and R&D initiatives by pharmaceutical companies

· Some of the key players are Novartis AG; Ipsen Pharma; Pfizer Inc.; and Chiasma Inc.

Grand View Research has segmented the global acromegaly treatment market on the basis of product, end use and region:

Acromegaly Treatment Product Outlook (Revenue, USD Million, 2014 - 2025)

· Somatostatin Analogs

· GHRA

· Others

Acromegaly Treatment End Use Outlook (Revenue, USD Million, 2014 - 2025)

· Hospitals & Clinics

· Others

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/pharmaceuticals

About Grand View Research

For more market analysis reports, please visit: http://www.grandviewresearch.com/

What is the Market Size of the Ovarian Cancer Diagnostics Market?

18-Mar-2020: The global ovarian cancer diagnostics market size is expected to reach USD 2 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.2%. The growth of the market can be attributed to an increase in the prevalence of ovarian cancer and emergence of novel diagnostic products. As of 2018, ovarian cancer had the highest mortality rate of all gynecologic cancers. It accounted for nearly 14,000 deaths in the U.S. in 2018. No specific symptoms render early diagnosis of the disease increasingly difficult. The exact causative factors remain unknown, creating a key unmet need for further research to obtain clarity on the underlying molecular mechanisms.

Women aged 60 years & above have a higher predisposition to it. As it is often diagnosed in advanced stages, treatment options are limited. Moreover, on the basis of race, incidence rates were higher among Caucasian women than African-American women. The International Federation of Gynecology and Obstetrics (FIGO) system is used for staging ovarian cancer. Staging process helps identify ovarian tumors, calculate their size, and detect invasion & metastasis.

Early detection and diagnosis significantly improve patient survival rates. For instance, in case of epithelial tumors, patients with stage 1 ovarian cancer have a survival rate of nearly 90%, whereas patients with stage 4-the most advanced phase-have a mere 15% survival rate. Technological advancements in PET and MRI as well as in diagnosis of BRCA mutations have positively impacted market growth.

The diagnostic landscape is gradually shifting toward genetic testing and counseling. As the disease bears a high risk of inheritance of gene mutation, guidelines pertaining to ovarian cancer diagnostics recommend all patients to undergo genetic counseling and testing. Earlier, BRCA1/2 was the most prominent test; however, advancements in medical science have now made it possible to test more than 20 genes in each patient.

In depth research report on Ovarian Cancer Diagnostics Market

https://www.grandviewresearch.com/industry-analysis/ovarian-cancer-diagnostics-market

Further key findings from the report suggest:

· Incidence of ovarian cancer worldwide has been declining over the past decades

· Although ultrasound imaging is the fist-line of diagnosis, the technique cannot be used for staging the disease

· Computerized Tomography (CT) imaging is preferred for staging the disease

· CA125 remained the mainstay in blood test biomarkers in 2018

· HER2 and BRCA1/2 tests are expected to witness a rapid growth during the forecast period owing to the rising awareness of early diagnosis and genetic tests

· The ovarian cancer diagnostics market in Asia Pacific is expected to grow at a high rate during the forecast period.

Grand View Research has segmented the global ovarian cancer diagnostics market on the basis of cancer type, diagnosis type, end use, and region:

Ovarian Cancer Diagnostics Cancer Type Outlook (Revenue, USD Million, 2015 - 2026)

· Epithelial Tumor

· Germ Cell Tumor

· Stromal Cell Tumor

· Others

Ovarian Cancer Diagnostics Diagnosis Type Outlook (Revenue, USD Million, 2015 - 2026)

· Imaging

· Ultrasound

· CT Scan

· MRI Scan

· PET Scan

· Others

· Blood Test

· CA125

· HER2

· BRCA

· CEA

· ER & PR

· KRAS Mutation

· Others

· Biopsy

· Others

Ovarian Cancer Diagnostics End-use Outlook (Revenue, USD Million, 2015 - 2026)

· Hospital Laboratories

· Cancer Diagnostic Centers

· Research Institutes

· Others

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/clinical-diagnostics

About Grand View Research

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Thursday, 12 March 2020

What will be the upcoming trends in Aromatherapy Carrier Oil Market?

13-Mar-2020: The global aromatherapy carrier oil market is expected to account for USD 1.90 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10%. Growing awareness and increasing use of therapeutic carrier oils has led to high market growth. Aromatherapy is considered an alternative to medicinal therapy for treatment of a wide range of conditions. Thus, with growing awareness about the field of alternative & complementary medicine, therapeutic-grade carrier oils are increasingly being adopted due to their healing properties.

In addition, adoption of natural products has increased as a number of adverse effects are associated with pharmaceutical products. For instance, apricot kernel oil is widely used for skin & hair care and scar & pain management as well as in manufacturing of soaps.

Aromatherapy products such as carrier oils have also been proven to be highly effective in pain management and healing of wounds & cuts. These products consist of healing as well as antibacterial properties.

In depth research report on Aromatherapy Carrier Oil Market

https://www.grandviewresearch.com/industry-analysis/aromatherapy-carrier-oil-market

Further key findings from the study suggest:

· Cosmetics segment dominated the aromatherapy carrier oils market in 2018 and is anticipated to grow at a lucrative rate during the forecast period owing to increase in incidence of skin and hair problems

· Medical segment also held significant share in 2018 owing to growing awareness about the various types of therapeutic-grade products available

· Rapid industrialization and increasing consumer awareness regarding new medical practices have led to an increase in demand for these products globally

· In 2018, personal care segment was expected to witness lucrative CAGR over the forecast period owing to increase in use of carrier oils as a base for manufacturing soaps

· North America held the largest market share in 2018 owing to rise in the number of key players introducing therapeutic grade products in the U.S.

· Lucrative trading opportunities have led to an increase in growth potential of the European market

· Asia Pacific is projected to exhibit significant growth rate over the forecast period due to growing awareness pertaining to aromatherapy as well as rise in incidence of skin disorders in this region

· Some of the key companies are Edens Garden, Rocky Mountain Oils, Plant Therapy Essential Oils, Falcon Essential Oils, FLORIHANA, and Moksha Lifestyle Products

Grand View Research has segmented the aromatherapy carrier oils market on the basis of application and region:

Aromatherapy Carrier Oils Application Outlook (Revenue, USD Million, 2015 - 2026)

· Cosmetic

· Skin Care

· Others

· Personal Care

· Household

· Soap

· Food & Beverages

· Medical

· Pain Management

· Cold & Cough

· Others

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/pharmaceuticals

About Grand View Research

For more market analysis reports, please visit: http://www.grandviewresearch.com/

Ophthalmic Perimeters Market is Anticipated to Reach USD 357.9 Million by 2026: Grand View Research, Inc.

12-Mar-2020: The global ophthalmic perimeters market size is anticipated to reach USD 357.9 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.1% over the forecast period. Growing frequency of new product launches and increasing number of strategic alliances between players & end users are some of the major factors expected to boost growth.

North America is anticipated to dominate the ophthalmic perimeters market during the forecast period owing to rising lifestyle and age-associated ophthalmic conditions such as glaucoma and cataract. Increase in demand for advanced early diagnostic techniques, high adoption rate for advanced technologies, and favorable reimbursement scenario are some of the major factors driving the market in the region.

A significant number of ophthalmic perimeter manufacturers are in North America. These players are emphasizing on developing user-friendly ophthalmic perimeter devices by developing image processing software. Moreover, key players are conducting workshops and training programs. Such initiatives are expected to boost the overall growth. The market is witnessing a rise in technologically advanced ophthalmic perimeter devices in the market due to high competition. Development of patented, tablet-based visual field testing and analysis system is anticipated to enable easy, faster, & accurate diagnosis.

In depth research report on Ophthalmic Perimeters Market

https://www.grandviewresearch.com/industry-analysis/ophthalmic-perimeters-market

Further key findings from the report suggest:

· Static perimeters segment held maximum share in 2018 owing to its extensive use in capturing large data points for visual field testing. Moreover, these devices conduct visual field testing from multiple angles, which in turn helps with accurate diagnosis.

· Combination perimeters segment is expected to grow at a fastest pace during the forecast period. These devices enable standardization of procedures and decrease the overall turnaround time.

· Hospital held largest share among the end-use segment. High demand for advanced ophthalmic perimeters in hospitals is driving segment growth.

· Ophthalmic clinic is expected to experience fastest growth during the forecast period. The segment growth is fueled by increasing number of standalone ophthalmic clinics in developing regions.

Grand View Research has segmented the global ophthalmic perimeters market on the basis of product type, application, end use, and region:

Ophthalmic Perimeters Product Outlook (Revenue, USD Million, 2015 - 2026)

· Static

· Kinetic

· Combination

Ophthalmic Perimeters End-use Outlook (Revenue, USD Million, 2015 - 2026)

· Hospital

· Ophthalmic Clinic

· Others

Browse more research reports of this category:

https://www.grandviewresearch.com/industry/medical-devices

About Grand View Research

For more market analysis reports, please visit: http://www.grandviewresearch.com/